Company Overview of Sequus Pharmaceuticals, Inc.
Sequus Pharmaceuticals, Inc. manufactures, develops, and distributes pharmaceutical products to treat cancer and infectious diseases. The company develops and markets DOXIL, an anticancer drug; and AMPHOTEC, an antifungal drug in the United States. The company was formerly known as Liposome Technology, Inc. and changed its name to Sequus Pharmaceuticals, Inc. in June 1995. The company was founded in 1981 and is based in Menlo Park, California. As of March 17, 1999, Sequus Pharmaceuticals, Inc. operates as a subsidiary of ALZA Corporation.
960 Hamilton Court
Menlo Park, CA 94025
Founded in 1981
Key Executives for Sequus Pharmaceuticals, Inc.
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Bloomberg L.P.||United States|
Sponsored Financial Commentaries
To contact Sequus Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.